BlackRock Fund Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $27.8M | Buy |
3,219,577
+360,423
| +13% | +$3.11M | 0.01% | 1997 |
|
|
2016
Q3 | $18.1M | Buy |
2,859,154
+139,469
| +5% | +$883K | ﹤0.01% | 2124 |
|
|
2016
Q2 | $11.5M | Sell |
2,719,685
-6,111
| -0.2% | -$25.8K | ﹤0.01% | 2325 |
|
|
2016
Q1 | $11.9M | Buy |
2,725,796
+21,002
| +0.8% | +$91.6K | ﹤0.01% | 2268 |
|
|
2015
Q4 | $16.6M | Sell |
2,704,794
-135,302
| -5% | -$829K | ﹤0.01% | 2160 |
|
|
2015
Q3 | $16.2M | Buy |
2,840,096
+99,942
| +4% | +$572K | ﹤0.01% | 2124 |
|
|
2015
Q2 | $20.4M | Sell |
2,740,154
-53,252
| -2% | -$397K | ﹤0.01% | 2103 |
|
|
2015
Q1 | $16.7M | Buy |
2,793,406
+48,237
| +2% | +$288K | ﹤0.01% | 2165 |
|
|
2014
Q4 | $20.8M | Buy |
2,745,169
+228,202
| +9% | +$1.73M | 0.01% | 2051 |
|
|
2014
Q3 | $13.1M | Sell |
2,516,967
-77,873
| -3% | -$404K | ﹤0.01% | 2200 |
|
|
2014
Q2 | $11.2M | Sell |
2,594,840
-166,489
| -6% | -$718K | ﹤0.01% | 2353 |
|
|
2014
Q1 | $11.3M | Buy |
2,761,329
+428,364
| +18% | +$1.75M | ﹤0.01% | 2331 |
|
|
2013
Q4 | $12.4M | Sell |
2,332,965
-40,591
| -2% | -$216K | ﹤0.01% | 2256 |
|
|
2013
Q3 | $11.9M | Buy |
2,373,556
+644,556
| +37% | +$3.24M | ﹤0.01% | 2249 |
|
|
2013
Q2 | $7.71M | Buy |
+1,729,000
| New | +$7.71M | ﹤0.01% | 2424 |
|